Press "Enter" to skip to content

Researchers end unsuccessful advanced-stage HIV vaccine trial

By Simon Druker

Jan. 18 (UPI) — Researchers working on a late-stage trial for an HIV vaccine said Wednesday they are discontinuing their work, ending the latest hope for a breakthrough.

The National Institutes of Health confirmed the news of the investigational trial of Mosaico, which began in 2019. It was the only HIV vaccine currently in a late-stage clinical trial.

The vaccine was initially developed by Janssen Vaccines & Prevention, owned by parent Johnson & Johnson. Patients received four injections over a year of the vaccine, which used a cold virus to deliver immunogens.

Read Full Article Here…(

Caravan to Midnight

We Need Your Help To Keep Caravan To Midnight Going

Please Consider Donating To Help Keep Independent Media Independent

Be First to Comment

Leave a Reply

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Breaking News: